Rep. Mark Desaulnier Questions Witness on NIH and ACA Cuts' Impact on Life Expectancy

Personal Health Journey and Healthcare System Critique

• 💡 Mark Desaulnier, a survivor of stage four chronic lymphocytic leukemia (CLL) and a former cancer patient, shares his personal experience with the American healthcare system.
• 🎯 He highlights that despite paying the most for healthcare among developed nations, the U.S. has the worst outcomes, likening it to a failing business.

Healthcare Denials and Incompetence

• ⚠️ Desaulnier recounts the story of Tracy Pike, who was denied a life-saving stomach cancer operation after initial approvals, leading to his death, questioning if this is an anomaly.
• 🔍 Bethany Lilly confirms that such denials are increasingly common, especially as healthcare costs rise, and notes a lack of transparency in employer-sponsored insurance denials.
• 📊 Lilly points out that the Office of Inspector General has found extremely high denial rates in Medicaid managed care and Medicare Advantage.
• 🗣️ A significant portion of consumers are unaware they can appeal denials, with over 50% having no knowledge of this right, according to a Kaiser Family Foundation survey.

Impact of NIH and ACA Cuts on Research and Life Expectancy

• 🔬 Desaulnier emphasizes that his survival from leukemia is due to decades of research investment at NIH and NCI, noting that half of current cancer treatments were developed by NCI.
• 📈 He expresses deep concern that cuts to NIH and ACA will negatively impact life expectancy and the development of new treatments.
• 💰 Lilly states that America has led in biomedical research for decades, and while monitoring the situation, she is very concerned about the potential consequences of these cuts.

Prescription Drug Pricing and Market Intervention

• 💊 Desaulnier shares an example of a prescription drug costing $500 in the U.S. but $37 in Australia and $90 in the EU after the Biden administration negotiated prices.
• ⚖️ He argues that while free markets are beneficial, some parameters are necessary, especially in a mixed-market economy.